Gene therapies have the potential to cure some diseases, but they are extraordinarily expensive. Location can also be a big ...

These patients, who may have high-deductible health plans or co-insurance, will be able to purchase both the pill and injection forms of obesity treatment Wegovy, the Ozempic diabetes shot, and oral ...

The cuts aim to make the drugs more accessible to insured patients, particularly people with high-deductible health plans or ...

Novo Nordisk will cut prices of the diabetes and weight loss drugs Ozempic, Rybelsus and Wegovy to $675 effective Jan. 1, 2027.

Starting in 2027, the Danish pharma firm will sell its weight-loss and diabetes drugs for $675 per month.

The price of the popular GLP-1 medications will be cut, starting in January of 2027, manufacturer Novo Nordisk said in a ...

Battling to regain its market share over rival Eli Lilly, Novo Nordisk announced Tuesday that it will reduce the list prices of its popular weight loss drug Wegovy and diabetes drugs Ozempic and ...

Cancer treatment costs declined as much as 8.2% in cities where most hospitals published complete pricing data for oncology services, new research shows, indicating that federal price transparency ...

Study: fuller hospital price disclosure tied to up to 8.2% lower cancer prices in markets with broad compliance.

Novo Nordisk announced plans to drastically reduce the list price of its versions, Wegovy, Ozempic and Rybelsus.